- ClearPoint Neuro (NASDAQ:CLPT) introduced that on August 23, 2024, it supplied for the total early reimbursement of the principal quantity and curiosity on a $10M convertible note held by PTC Therapeutics which might have matured in January 2025 in response to its phrases.
- The convertible note was issued by the corporate pursuant to a financing transaction which was accomplished in January 2020.
- Source: Press Release
Source: Seekingalpha
